The impact of ambidextrous market learning and product innovativeness on product advantage and new product performance

New Product Development is vital to the performance of high-tech firms given the rapid change in technology and markets that they face. Drawing on the ambidexterity literature this study focuses on how firms can employ Ambidextrous Market Learning (AML), that is, the use of exploratory and exploitative market learning strategies simultaneously, to develop successful innovative products. Despite the exponential growth of studies focusing on ambidexterity, the literature portrays the ambidexterity concept as a present or absent like phenomena. However, in the current study, AML is conceptualised as a continuum of market knowledge that acts as a key source essential in creating customer value in the form of new products. Whilst research into ambidexterity contains abundant evidence of the positive effects of ambidexterity on firm performance, yet there is little discussion in the literature on the effects of AML on product advantage and the role of product innovativeness. A conceptual model comprising the relationship between AML, product advantage and product innovativeness is developed and empirically tested using 178 UK-based high-tech firms. The findings indicate that AML firms tend to develop products that have high product advantage. The study further focuses on how product innovativeness and product advantage constructs interact to create new product financial performance. Findings also suggest that marketing and technological discontinuity (product innovativeness from the firm s perspective) respectively has a negative and a positive moderating impact on product advantage. In addition, modelling product innovativeness from the customers perspective (customer discontinuity) in the same model sheds new light on the relationship between product advantage, product innovativeness and product performance. By further examining the moderating effects of marketing and technological discontinuity on the link between AML and product advantage, the analyses reveals the different scenarios in which the benefits of AML firms may outweigh its implementation cost

A Typology of Viral Ad Sharers Using Sentiment Analysis

Viral advertising is the most popular manifestation of viral marketing phenomena. The purpose of this study is to demonstrate sentiment analysis as a promising tool to quantify consumer responses towards branded viral video advertisements and thereupon, propose a sentiment-based typology of viral ad sharers. Results of this experimental study (1) suggest that sentiment-based measures of consumer responses offer better prediction of consumers’ ad sharing intentions compared to the traditional and widely used thought-listing method; and (2) help identify four distinct segments of viral ad sharers (based on the relative strength of ad- and brand-related sentiments), namely: “Active”, “Brand-fanatic”, “Content-hungry”, and “Dormant”, labeled as ABCD typology of viral ad sharers. This study highlights that for creating successful viral campaigns, marketers should consider the distinctive characteristics of these four segments of viral ad sharers (based on their processing of ad content and brand information) to identify the right seeds to initiate a viral campaign

Threat, Efficacy and Message Framing in Consumer Healthcare

Purpose: The purpose of this paper is to empirically examine the interactive effects of message framing, perceived threat and efficacy appeals on attitudes/intentions towards consumer healthcare communications, particularly, cataract surgery. Design/methodology/approach: This paper develops two conceptual models dealing with threat, efficacy and framing and tests them with data collected from two field experiments. Findings: The results reveal that high efficacy messages in combination with high threat or loss-framed messages have a significant positive influence on consumer attitudes and intentions in the consumer healthcare arena. Practical implications: The findings have managerial value and public policy implications for healthcare officials in developing effective communications material. Specifically, this paper recommends that high threat, high efficacy and loss-framed efficacy messages be used. Originality/value: This research extends previous work by demonstrating the effectiveness of threat appeals and framing on consumer attitudes and intentions to undergo cataract surgery. It also demonstrates the use of communication models in the healthcare domain

Parallel finite element simulation of large ram-air parachutes

In the near future, large ram-air parachutes are expected to provide the capability of delivering 21 ton payloads from altitudes as high as 25,000 ft. In development and test and evaluation of these parachutes the size of the parachute needed and the deployment stages involved make high-performance computing (HPC) simulations a desirable alternative to costly airdrop tests. Although computational simulations based on realistic, 3D, time-dependent models will continue to be a major computational challenge, advanced finite element simulation techniques recently developed for this purpose and the execution of these techniques on HPC platforms are significant steps in the direction to meet this challenge. In this paper, two approaches for analysis of the inflation and gliding of ram-air parachutes are presented. In one of the approaches the point mass flight mechanics equations are solved with the time-varying drag and lift areas obtained from empirical data. This approach is limited to parachutes with similar configurations to those for which data are available. The other approach is 3D finite element computations based on the Navier-Stokes equations governing the airflow around the parachute canopy and Newton's law of motion governing the 3D dynamics of the canopy, with the forces acting on the canopy calculated from the simulated flow field. At the earlier stages of canopy inflation the parachute is modelled as an expanding box, whereas at the later stages, as it expands, the box transforms to a parafoil and glides. These finite element computations are carried out on the massively parallel supercomputers CRAY T3D and Thinking Machines CM-5, typically with millions of coupled, non-linear finite element equations solved simultaneously at every time step or pseudo-time step of the simulation

FIC/FEM formulation with matrix stabilizing terms for incompressible flows at low and high Reynolds numbers

The final publication is available at Springer via http://dx.doi.org/10.1007/s00466-006-0060-yWe present a general formulation for incompressible fluid flow analysis using the finite element method. The necessary stabilization for dealing with convective effects and the incompressibility condition are introduced via the Finite Calculus method using a matrix form of the stabilization parameters. This allows to model a wide range of fluid flow problems for low and high Reynolds numbers flows without introducing a turbulence model. Examples of application to the analysis of incompressible flows with moderate and large Reynolds numbers are presented.Peer ReviewedPostprint (author's final draft

Guidelines for the Development of Comprehensive Care Centers for Congenital Adrenal Hyperplasia: Guidance from the CARES Foundation Initiative

Patients with rare and complex diseases such as congenital adrenal hyperplasia (CAH) often receive fragmented and inadequate care unless efforts are coordinated among providers. Translating the concepts of the medical home and comprehensive health care for individuals with CAH offers many benefits for the affected individuals and their families. This manuscript represents the recommendations of a 1.5 day meeting held in September 2009 to discuss the ideal goals for comprehensive care centers for newborns, infants, children, adolescents, and adults with CAH. Participants included pediatric endocrinologists, internal medicine and reproductive endocrinologists, pediatric urologists, pediatric surgeons, psychologists, and pediatric endocrine nurse educators. One unique aspect of this meeting was the active participation of individuals personally affected by CAH as patients or parents of patients. Representatives of Health Research and Services Administration (HRSA), New York-Mid-Atlantic Consortium for Genetics and Newborn Screening Services (NYMAC), and National Newborn Screening and Genetics Resource Center (NNSGRC) also participated. Thus, this document should serve as a “roadmap” for the development phases of comprehensive care centers (CCC) for individuals and families affected by CAH

Guidelines for the Development of Comprehensive Care Centers for Congenital Adrenal Hyperplasia: Guidance from the CARES Foundation Initiative

Patients with rare and complex diseases such as congenital adrenal hyperplasia (CAH) often receive fragmented and inadequate care unless efforts are coordinated among providers. Translating the concepts of the medical home and comprehensive health care for individuals with CAH offers many benefits for the affected individuals and their families. This manuscript represents the recommendations of a 1.5 day meeting held in September 2009 to discuss the ideal goals for comprehensive care centers for newborns, infants, children, adolescents, and adults with CAH. Participants included pediatric endocrinologists, internal medicine and reproductive endocrinologists, pediatric urologists, pediatric surgeons, psychologists, and pediatric endocrine nurse educators. One unique aspect of this meeting was the active participation of individuals personally affected by CAH as patients or parents of patients. Representatives of Health Research and Services Administration (HRSA), New York-Mid-Atlantic Consortium for Genetics and Newborn Screening Services (NYMAC), and National Newborn Screening and Genetics Resource Center (NNSGRC) also participated. Thus, this document should serve as a “roadmap” for the development phases of comprehensive care centers (CCC) for individuals and families affected by CAH

Guidelines for the Development of Comprehensive Care Centers for Congenital Adrenal Hyperplasia: Guidance from the CARES Foundation Initiative

Patients with rare and complex diseases such as congenital adrenal hyperplasia (CAH) often receive fragmented and inadequate care unless efforts are coordinated among providers. Translating the concepts of the medical home and comprehensive health care for individuals with CAH offers many benefits for the affected individuals and their families. This manuscript represents the recommendations of a 1.5 day meeting held in September 2009 to discuss the ideal goals for comprehensive care centers for newborns, infants, children, adolescents, and adults with CAH. Participants included pediatric endocrinologists, internal medicine and reproductive endocrinologists, pediatric urologists, pediatric surgeons, psychologists, and pediatric endocrine nurse educators. One unique aspect of this meeting was the active participation of individuals personally affected by CAH as patients or parents of patients. Representatives of Health Research and Services Administration (HRSA), New York-Mid-Atlantic Consortium for Genetics and Newborn Screening Services (NYMAC), and National Newborn Screening and Genetics Resource Center (NNSGRC) also participated. Thus, this document should serve as a “roadmap” for the development phases of comprehensive care centers (CCC) for individuals and families affected by CAH

Guidelines for the Development of Comprehensive Care Centers for Congenital Adrenal Hyperplasia: Guidance from the CARES Foundation Initiative

Abstract Patients with rare and complex diseases such as congenital adrenal hyperplasia (CAH) often receive fragmented and inadequate care unless efforts are coordinated among providers. Translating the concepts of the medical home and comprehensive health care for individuals with CAH offers many benefits for the affected individuals and their families. This manuscript represents the recommendations of a 1.5 day meeting held in September 2009 to discuss the ideal goals for comprehensive care centers for newborns, infants, children, adolescents, and adults with CAH. Participants included pediatric endocrinologists, internal medicine and reproductive endocrinologists, pediatric urologists, pediatric surgeons, psychologists, and pediatric endocrine nurse educators. One unique aspect of this meeting was the active participation of individuals personally affected by CAH as patients or parents of patients. Representatives of Health Research and Services Administration (HRSA), New York-Mid-Atlantic Consortium for Genetics and Newborn Screening Services (NYMAC), and National Newborn Screening and Genetics Resource Center (NNSGRC) also participated. Thus, this document should serve as a "roadmap" for the development phases of comprehensive care centers (CCC) for individuals and families affected by CAH